If we receive a notification that the material you post, upload, edit, host, share, send, broadcast, broadcast, broadcast and/or publish (“User Contribution”) is inappropriate, the rights of a third party are infringed or, for any reason, we reserve the right to immediately or otherwise remove the User`s messages, that of us in our sole discretion. The user`s address is deleted without acknowledgment of liability and without prejudice to any rights, remedies or defenses, all expressly reserved. You acknowledge and agree that Tandem is not required to set aside such contributions at any time. If user contributions infringe your rights (including intellectual property rights) or if you believe that the user`s contributions violate or are illegal (including intellectual property rights), please contact us immediately via the In-App feature or by contacting us by email: www.tandem.net/contact-us. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or anticipated in the forward-looking or anticipated statements. These forward-looking statements relate to, among other things, the Company`s distribution agreement with Rubin Medical and the expected availability of the Company`s products outside the United States. The Company`s actual results may differ materially from the results set forth in these forward-looking statements due to numerous risks and uncertainties, including risks related to the development of new products in general, including possible delays in the Company`s product development programs; possible future actions taken by supervisory or government authorities, including the company`s potential not to obtain the CE marking for the company`s products if expected; the potential to terminate the Company`s agreement with Rubin Medical; and other risks identified in Tandem`s most recent Annual Report on Form 10-K or quarterly reports on Form 10-Q and other documents we submit to the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only at the time of this press release. Companies undertake no representation to update or review any forward-looking statements contained in this press release based on new information, future events or other factors. Follow tandem diabetes care on Twitter @tandemdiabetes; use #tslimX2 and $TNDM.